These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30326209)

  • 21. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
    Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
    Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gas-pressurized dispersive powder flow tester for low volume sample characterization.
    Majid AM; Wong TW
    Int J Pharm; 2013 May; 448(1):150-8. PubMed ID: 23506957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a robust procedure for assessing powder flow using a commercial avalanche testing instrument.
    Hancock BC; Vukovinsky KE; Brolley B; Grimsey I; Hedden D; Olsofsky A; Doherty RA
    J Pharm Biomed Anal; 2004 Sep; 35(5):979-90. PubMed ID: 15336345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW; Luo Y; Liao ZG; Zhao GW; Li Z; Luo J
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multivariate methodology for material sparing characterization and blend design in drug product development.
    Dhondt J; Eeckhout Y; Bertels J; Kumar A; Van Snick B; Klingeleers D; Vervaet C; De Beer T
    Int J Pharm; 2022 Jun; 621():121801. PubMed ID: 35526701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of a low-dose capsule filling process by dynamic and static tests for advanced process understanding.
    Stranzinger S; Faulhammer E; Scheibelhofer O; Calzolari V; Biserni S; Paudel A; Khinast JG
    Int J Pharm; 2018 Apr; 540(1-2):22-30. PubMed ID: 29407875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine powder flow under humid environmental conditions from the perspective of surface energy.
    Karde V; Ghoroi C
    Int J Pharm; 2015 May; 485(1-2):192-201. PubMed ID: 25772418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial neural networks (ANNs) and modeling of powder flow.
    Kachrimanis K; Karamyan V; Malamataris S
    Int J Pharm; 2003 Jan; 250(1):13-23. PubMed ID: 12480269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
    Bosquillon C; Lombry C; Préat V; Vanbever R
    J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the tensile strength of compacted multi-component mixtures of pharmaceutical powders.
    Wu CY; Best SM; Bentham AC; Hancock BC; Bonfield W
    Pharm Res; 2006 Aug; 23(8):1898-905. PubMed ID: 16850273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commercial scale validation of a process scale-up model for lubricant blending of pharmaceutical powders.
    Kushner J; Schlack H
    Int J Pharm; 2014 Nov; 475(1-2):147-55. PubMed ID: 25152166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
    Villanova JC; Ayres E; Oréfice RL
    Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New indices to characterize powder flow based on their avalanching behavior.
    Soh JL; Liew CV; Heng PW
    Pharm Dev Technol; 2006 Feb; 11(1):93-102. PubMed ID: 16544913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.